Cargando…

TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo

Prostate cancer is the most prevalent cancer in males in developed countries. Tumor suppressor candidate 3 (TUSC3) has been identified as a putative tumor suppressor gene in prostate cancer, though its function has not been characterized. TUSC3 shares homologies with the yeast oligosaccharyltransfer...

Descripción completa

Detalles Bibliográficos
Autores principales: Horak, Peter, Tomasich, Erwin, Vaňhara, Petr, Kratochvílová, Kateřina, Anees, Mariam, Marhold, Maximilian, Lemberger, Christof E., Gerschpacher, Marion, Horvat, Reinhard, Sibilia, Maria, Pils, Dietmar, Krainer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894551/
https://www.ncbi.nlm.nih.gov/pubmed/24435307
http://dx.doi.org/10.1038/srep03739
Descripción
Sumario:Prostate cancer is the most prevalent cancer in males in developed countries. Tumor suppressor candidate 3 (TUSC3) has been identified as a putative tumor suppressor gene in prostate cancer, though its function has not been characterized. TUSC3 shares homologies with the yeast oligosaccharyltransferase (OST) complex subunit Ost3p, suggesting a role in protein glycosylation. We provide evidence that TUSC3 is part of the OST complex and affects N-linked glycosylation in mammalian cells. Loss of TUSC3 expression in DU145 and PC3 prostate cancer cell lines leads to increased proliferation, migration and invasion as well as accelerated xenograft growth in a PTEN negative background. TUSC3 downregulation also affects endoplasmic reticulum (ER) structure and stress response, which results in increased Akt signaling. Together, our findings provide first mechanistic insight in TUSC3 function in prostate carcinogenesis in general and N-glycosylation in particular.